German industrial conglomerate Siemens is debating a listing on a U.S. stock exchange for Siemens Healthineers when the division is spun off as an independent company later this year, according to a report by Reuters.
An article published February 10 in Reuters quoted an interview by German newspaper Euro am Sonntag with Siemens CEO Joe Kaeser, in which he revealed that the company is looking at listing Siemens Healthineers on a U.S. exchange rather than one in Europe.
Stock valuations on U.S. exchanges are higher right now than in Europe, which would make such a listing advantageous for Siemens, he told the newspaper.
Siemens is in the process of preparing an initial public offering for Siemens Healthineers that would open the company up to outside investors while Siemens retained a significant stake.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
